KALA BIO, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported net loss was USD 8.7 million compared to net income of USD 29.07 million a year ago. Basic loss per share from continuing operations was USD 3.41 compared to basic earnings per share from continuing operations of USD 19.39 a year ago. Diluted loss per share from continuing operations was USD 3.41 compared to diluted earnings per share from continuing operations of USD 19.25 a year ago.
For the nine months, net loss was USD 33.57 million compared to USD 31.98 million a year ago. Basic loss per share from continuing operations was USD 14.36 compared to USD 21.46 a year ago. Diluted loss per share from continuing operations was USD 14.36 compared to USD 21.46 a year ago.